Newsletter | May 8, 2025

05.08.25 -- Wearables: An Essential For Decentralized Clinical Trials

SPONSOR

DIA 2025 Global Annual Meeting

In a time of rapid change, no single discipline can move forward alone. DIA 2025 Global Annual Meeting (DIA 2025) brings together regulatory, clinical, safety, and operational leaders to confront shared challenges and design smarter, faster, more connected solutions. From real-time FDA insights to global regulatory and multi-disciplinary collaboration, DIA 2025 is where silos break down and progress accelerates. Join the conversation that’s shaping what’s next!

FEATURED EDITORIAL

Wearables: An Essential For Decentralized Clinical Trials

Bryan Hansen, Ph.D., director of Innovative Health at Johnson & Johnson Innovative Medicine, discusses types of wearables, his experience using them in neurological disease clinical trials, and some future plans for these devices.

INDUSTRY INSIGHTS

Unleash The Power Of IQVIA Complete Consent

Join Vinita Navadgi, and Amy Koller from IQVIA Complete Consent for an in-depth exploration of the eConsent landscape.

Modernizing Clinical Research With AI And Digital Data

Discover how ActiGraph is revolutionizing clinical trials with patient-focused digital data and cutting-edge technology that enhances trial efficiency across all phases.

Leading eSource Software Company Receives Part 11/Annex 11 Verification

Uncover how an independent confirmation of compliance opened up new opportunities and is instilling confidence in customers who are integrating the eSource system into their software validation strategy.

The Future Of Wearable Technology In Clinical Trials

Learn how wearable technology is reshaping the future of clinical trials, offering opportunities to collect continuous, real-time health data while improving patient access and engagement.